In the wake of the global pandemic, a new health concern has entered the spotlight: monkeypox. But recent revelations have added a twist to the narrative, sparking debate and concern. Some sources are now linking the monkeypox outbreak not just to natural causes but to Covid-19 vaccines themselves. With claims that monkeypox might actually be a side effect of these vaccines, we find ourselves once again in the midst of a heated debate about vaccine safety, transparency, and public health. Let’s explore the issue in more detail.
The WHO’s Hidden Admission?
Recently, attention has turned to the World Health Organization’s (WHO) VigiAccess database, which lists potential side effects of approved vaccines, including the Pfizer-BioNTech Covid-19 vaccine. Hidden among these lists are conditions like “smallpox,” “cowpox,” and, controversially, “monkeypox.” These revelations have prompted many to question whether monkeypox cases are indeed a natural outbreak or a side effect of the Covid-19 vaccine rollout.
To further complicate matters, this information isn’t easy to find. The VigiAccess website contains a labyrinthine database that’s not exactly user-friendly. Buried under a category labeled “Infections and Infestations,” the terms “smallpox,” “cowpox,” and “monkeypox” appear alongside hundreds of other potential side effects of the Pfizer vaccine. For some, this is a red flag—an indication that vital information is being obscured rather than openly shared. For others, this could just be the reality of cataloguing medical data in all its complex forms.
Fear, Hoaxes, and Misinformation
The conversation doesn’t stop at just data. Some experts, like German doctor Wolfgang Wodarg, have come forward to suggest that the monkeypox outbreak itself may be a hoax. In a recent interview, Dr. Wodarg claimed that the symptoms of monkeypox are, in fact, side effects of the Covid-19 vaccine, rather than an independent outbreak. If true, this raises troubling questions about transparency within the medical community and the role of public health organisations in addressing these concerns.
The core of Wodarg’s argument lies in the idea that global bodies like the WHO are more interested in profiting from testing and treatment than acknowledging potential links between vaccines and emerging health conditions. This claim, of course, has met with strong pushback, particularly from mainstream medical sources, which dismiss the notion that the monkeypox outbreak is anything but real. However, this type of debate underscores a broader issue: trust in global health institutions has been waning, and revelations like this don’t help to build confidence.
Vaccine Shedding: Another Layer of Concern
Adding fuel to the fire, the U.S. Food and Drug Administration (FDA) has also made an eyebrow-raising admission. According to documents released by the FDA, the monkeypox vaccine (ACAM2000), which was re-approved for use in the US, carries the risk of “shedding.” Shedding refers to the phenomenon where those who are vaccinated can pass on the live virus to others, particularly through close physical contact. This raises significant concerns, not only for those receiving the vaccine but also for those who may come into contact with them.
The side effects of this particular vaccine can be severe, ranging from heart complications to, in extreme cases, death. This information has led to understandable anxiety, especially in a world already fatigued by health scares and constant updates on new medical risks.
The Smallpox Connection
It’s important to note that the vaccine being used for monkeypox is not entirely new. It was initially developed to tackle smallpox—a disease eradicated decades ago. In 2024, the vaccine was repurposed to fight monkeypox, a move that has raised questions. Why use a smallpox vaccine for monkeypox? Are the two diseases closely enough related to justify this choice, or is there another reason?
Critics argue that the use of a smallpox vaccine to tackle monkeypox is yet another example of misdirection in global health. The smallpox vaccine itself has been linked to heart issues in a 2015 study conducted on military recruits, so why introduce this vaccine to the general public without a thorough explanation of the risks? Are we trading one problem for another by pushing a potentially harmful solution?
Where Do We Go From Here?
The debate over monkeypox, vaccines, and side effects brings us to a broader conversation about public health. We’re living in an age where information is readily available, but clarity seems harder to find. Global health institutions like the WHO are under immense pressure to address health crises while maintaining public trust, but controversies like these can erode the very confidence they need to operate effectively.
It’s clear that we need more transparency, especially when it comes to vaccine side effects and the potential risks associated with them. Public health is not just about containing diseases but also about ensuring that people have all the information necessary to make informed decisions. If there are risks—no matter how small—those risks should be communicated openly.
As we navigate this new health landscape, the onus is on global health leaders to foster an environment of trust. Hiding information or making it difficult to access only fuels suspicion. In an age where misinformation spreads like wildfire, transparency is the key to keeping the public informed and, ultimately, safe.
Original Article: Europe Reloaded
